In line with Pharmaline’s culture, we collaborate with academic institutions and private CROs by conducting bioequivalence studies.
These are carried out in accordance with Good Clinical Practice (GCP) guidelines and ethical standards for Human Experimentation established by the Declaration of Helsinki.
Several of our bioequivalence studies were published in peer -reviewed international journals:
- 1. Bustami R, Khasawneh S, Absi W, Feddah, H, Menassa M, Daccache E, Taha MS, Kyriacos S. Bioequivalence of a Fixed Dose Combination of Desloratadine/Betamethasone Tablets (Oradus Beta) in Healthy Human Volunteers. J Bioequiv Availab 2016; 8(5): 233-241.
- 2. Bustami R, Khasawneh S, Absi W, Feddah, H, Mroueh M, Daccache E, Sarraf JC, Kyriacos S. Bioequivalence of Losartan/Amlodipine Fixed Dose Combination Tablets (Losanet AM) Compared with Concomitant Administration of Single Components of Losartan and Amlodipine Tablets in healthy Human Volunteers. J Bioequiv Availab 2015; 7(5): 216-224.
- 3. Al-Ghazawi A, Idkaidek N, Daccache E, Sarraf JC, Kyriacos S. Bioequivalence of Two Pregabalin 300 mg capsules (Neurexal and Lyrica) in Healthy Human Volunteers. Drug Res 2014; 64:358-362.